Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial
Conclusion
Linagliptin + LD metformin combination showed similar efficacy and safety to HD metformin. This combination may be an alternative treatment option in patients who may have difficulty tolerating metformin doses >1000 mg/day.
Funding
Boehringer Ingelheim.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Fortamet | Gastroenterology | Metformin | Pain | Study